How Value Analysis Committees’ Lines of Questioning Can Directly Affect Value Equation Outputs
John Kelty from W.L. Gore & Associates discusses how value analysis committees can determine a medical devices value when evaluating new products.
Related Resources
Case Studies
AHRMM is offering a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a
Advisory
AHRMM’s Issues & Legislative Committee issued the following Statement on Pricing Transparency approved by AHRMM Board of Directors:<
Advisory
The Food and Drug Administration (FDA) UDI system is being phased in over several years.
Guides and Reports
In the fall of 2014, the University of Houston conducted a national study on hospital supply chain.
Guides and Reports
In 2001 the Institute of Medicine (IOM) published